Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

Summary

Renal dysfunction is a frequent complication in patients admitted to intensive care units (ICUs), associated with high morbidity and mortality. Current therapeutic options to prevent this condition are limited and lack robust scientific evidence. This pilot study consists of a multicenter, blinded, randomized clinical trial, unprecedented in the literature to date, aiming to fill this knowledge gap and offer new therapeutic perspectives to improve renal outcomes in critically ill patients admitted to the ICU.

Timeline

Start

2025-04-10

Primary completion

2025-10-10

Completion

2025-12-10

Drugs

Indications

No indication recorded.